Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer

Conclusion: HER2 IHC 2+ may indicate a decreased tpCR rate, bpCR rate, and apCR rate to neoadjuvant treatment in HR-positive patients having HER2-positive breast cancer, but not in HR-negative patients.

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Miaomiao Jia (Dahkki), Haibo Yang (Dahkki), Lihui Pan (Dahkki), Jinnan Gao (Dahkki), Fan Guo (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Hindawi-Wiley, 2024-01-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis